In the US, strong biotechnology research infrastructure and continued investment in biopharmaceutical development are supporting demand for media, sera, and reagents. Academic institutions, pharmaceutical companies, and biotechnology firms use these products extensively for cell culture and molecular research. Expansion of advanced therapeutic development is also creating opportunities for...